Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Obsessive-Compulsive Disorder Clinical Trials

59 recruiting trials for Obsessive-Compulsive Disorder. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
59
Total Trials
59
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07082777

Recovery in Telling Life Stories

This project tests the Recovery In Telling Life Stories (RETELL) intervention, aimed at supporting personal recovery in people with severe mental illness (SMI). While many of...

Sponsor: University of AarhusEnrolling: 201 location
RECRUITINGNCT06917339

Retrospective Analyses of TrakStar Database

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar...

Sponsor: NeuroneticsEnrolling: 1560001 location
RECRUITINGPhase 2NCT05783817

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Sponsor: Carolyn RodriguezEnrolling: 401 location
RECRUITINGNCT06347978

Personalized DBS for OCD Guided by Stereoencephalography Mapping

This is a double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6...

Sponsor: Andrew Moses Lee, MD, PhDEnrolling: 101 location
RECRUITINGNCT04958096

Cortical Stimulation to Treat Obsessive Compulsive Disorder

The purpose of this study is to identify abnormal brain signals associated with Obsessive Compulsive Disorder (OCD) and psychiatric symptoms and to investigate novel therapeutic...

Sponsor: Andrew Moses Lee, MD, PhDEnrolling: 151 location
RECRUITINGNCT05609916

CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.

Sponsor: Baylor College of MedicineEnrolling: 2001 location
RECRUITINGNCT06407648

Using Personalized Assessments in the Treatment of Childhood OCD

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are...

Sponsor: Johns Hopkins UniversityEnrolling: 301 location
RECRUITINGNCT05577585

Ketamine in OCD: Efficacy and Effects on Stress and Cognition

The main goal of this trial is to demonstrate therapeutic efficacy of low dose ketamine in patients with OCD. We expect that ketamine will alleviate symptoms in the hours...

Sponsor: Medical University of ViennaEnrolling: 601 location
RECRUITINGNCT06017713

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

This is a single-center study about patients with severe resistant OCD. Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right...

Sponsor: Centre Hospitalier Henri LaboritEnrolling: 251 location
RECRUITINGNCT05995951

Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder

This study will include two parts. The first part will include two patients in a non-blinded, non-randomized, open trial. They will undergo Deep Bran Stimulation (DBS) for OCD...

Sponsor: Rabin Medical CenterEnrolling: 101 location
RECRUITINGNCT01635569

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder (OCD) is a common neuropsychiatric illness beginning in childhood. Effective OCD treatments include cognitive-behaviour therapy (CBT) and medications...

Sponsor: University of British ColumbiaEnrolling: 1801 location
RECRUITINGNCT06494735

Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms

Obsessive-compulsive disorder (OCD) is a psychiatric illness characterized by the presence of obsessions and/or compulsions. Without effective treatment, symptoms tend to worsen...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 1141 location
RECRUITINGNCT06692114

Efficacy and Influencing Factors of Deep Transcranial Magnetic Stimulation in the Treatment of OCD

This study aims to explore the efficacy and influencing of accelerated dTMS (deep Transcranial Magnetic Stimulation) treatment in patients with obsessive-compulsive disorder...

Sponsor: Zhen WangEnrolling: 701 location
RECRUITINGNCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from...

Sponsor: Susanne WalitzaEnrolling: 1001 location
RECRUITINGNCT06542224

Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However,...

Sponsor: West China HospitalEnrolling: 164 locations
RECRUITINGNCT05623306

SEEG-Guided DBS for OCD

This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an...

Sponsor: Katherine ScangosEnrolling: 102 locations
RECRUITINGNCT07232823

Brief Culturally Adapted CBT for OCD

The purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).

Sponsor: Pakistan Association of Cognitive TherapistsEnrolling: 1661 location
RECRUITINGPhase 2NCT04882839

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by recurrent distressing thoughts and substantial anxiety, accompanied by repetitive behaviors or...

Sponsor: Beersheva Mental Health CenterEnrolling: 151 location
RECRUITINGNCT07031544

Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive...

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc)...

Sponsor: Shanghai Mental Health CenterEnrolling: 6010 locations
RECRUITINGNCT07245134

Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: A Randomized Controlled Trial in Inpatients

The aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). Participants are randomly...

Sponsor: National Institute of Mental Health, Czech RepublicEnrolling: 621 location
RECRUITINGNCT05577598

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment...

Sponsor: Medical University of ViennaEnrolling: 81 location
RECRUITINGNCT05467683

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a...

Sponsor: University of Texas at AustinEnrolling: 6002 locations
RECRUITINGPhase 2NCT05940324

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Stanford UniversityEnrolling: 1501 location
RECRUITINGNCT06262464

An OCD Prevention Programme for at Risk Adults

The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of...

Sponsor: Babes-Bolyai UniversityEnrolling: 2001 location
RECRUITINGNCT06346301

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD)....

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 361 location
RECRUITINGNCT04723485

Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood

Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most...

Sponsor: Susanne WalitzaEnrolling: 6251 location
RECRUITINGNCT05224414

Interpretation Bias as a Mechanism of Treatment Response in OCD

This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive...

Sponsor: Mclean HospitalEnrolling: 1061 location
RECRUITINGNCT07458100

The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders

The goal of this clinical trial is to evaluate the effectiveness and cost-effectiveness of a digital mindfulness-based intervention in adults (aged 18-65) diagnosed with emotional...

Sponsor: Peking UniversityEnrolling: 4641 location
RECRUITINGNCT06443125

Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis

explore objective indicators of the efficacy of natural psychotherapy in the treatment of disorders such as obsessive-compulsive disorder

Sponsor: Xiang Yang ZhangEnrolling: 502 locations
RECRUITINGNCT05377125

Neural Mechanisms of Response Inhibition Training for OCRD

The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, including...

Sponsor: University of Wisconsin, MilwaukeeEnrolling: 1181 location
RECRUITINGNCT06582225

ICBT for OCD in Children With Autism

The purpose of this trial is to evaluate the clinical efficacy, the cost-effectiveness and the effect durability of a therapist-guided, internet-delivered cognitive-behavior...

Sponsor: Karolinska InstitutetEnrolling: 2203 locations
RECRUITINGPhase 2NCT06611592

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD)

The most common and effective treatment for OCD is pharmacological therapy that includes selective serotonin reuptake inhibitors (SSRIs) antidepressants and, in the case of...

Sponsor: Clinical Academic Center (2CA-Braga)Enrolling: 481 location
RECRUITINGNCT05520398

Neural Mechanisms of Obsessive-compulsive Disorder (OCD) Treatment Failure

The aim of this study is to understand why patients with obsessive-compulsive disorder (OCD) fail in therapy. To understand the neural mechanisms involved in exposure therapy...

Sponsor: University College, LondonEnrolling: 901 location
RECRUITINGNCT06660225

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if deep brain stimulation (DBS) works to treat refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer...

Sponsor: Nader PouratianEnrolling: 101 location
RECRUITINGNCT07011901

Precision Analytic Research Methods in OCD

Psychiatric disorders characterized by compulsivity, such as obsessive-compulsive disorder (OCD), result in considerable functional impairment and many individuals do not respond...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 1001 location
RECRUITINGPhase 1NCT07347405

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

The study tries to improve our treatments for people who have obsessive-compulsive disorder (OCD) by testing psilocybin, a mind altering drug that changes activity in brain areas...

Sponsor: Francisco A MorenoEnrolling: 301 location
RECRUITINGNCT06942494

Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD

The goal of this clinical trial is to learn if self-help book can be used to treat obsessive-compulsive disorder (OCD) in adolescents aged 10 to 17. The main questions it aims to...

Sponsor: Shanghai Mental Health CenterEnrolling: 881 location
RECRUITINGNCT07116785

Accelerated Rotational Field Deep TMS for Treating OCD

A Prospective Double Blind Randomized Controlled Trial to Evaluate the Efficacy and Durability of the BrainsWay Rotational Field Deep Transcranial Magnetic Stimulation (Deep TMS)...

Sponsor: Ben-Gurion University of the NegevEnrolling: 501 location
RECRUITINGNCT02537795

Psychiatric Neurosurgery (PNS) for Obsessive Compulsive Disorder (OCD): A Qualitative Analysis of Patient and Family...

In this study the investigators will use semi-structured interviews to qualitatively analyse patient and family member experiences with either deep brain stimulation or other...

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 401 location
RECRUITINGNCT06628752

Deep Brain Stimulation for Obsessive-compulsive Disorder

The goal of this clinical trial is to evaluate the treatment method of deep brain stimulation (DBS) in patients diagnosed with severe and treatment-resistant obsessive-compulsive...

Sponsor: Umeå UniversityEnrolling: 261 location
RECRUITINGPhase 1NCT06299319

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD

Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 101 location
RECRUITINGNCT06466057

Metacognitive Therapy for Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to...

Sponsor: Northeast Normal UniversityEnrolling: 801 location
RECRUITINGNCT06173752

Mechanisms of Exposure Therapy for OCD

Exposure therapy is the most effective treatment available for obsessive compulsive disorder, yet up to 50% of patients do not recover because the mechanisms underlying successful...

Sponsor: Mclean HospitalEnrolling: 4002 locations
RECRUITINGNCT04934007

Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder

According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in...

Sponsor: Centre Hospitalier Henri LaboritEnrolling: 1362 locations
RECRUITINGPhase 1 / Phase 2NCT06575075

Pilot Study of RR-HNK in OCD

The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.

Sponsor: Carolyn RodriguezEnrolling: 451 location
RECRUITINGNCT04071990

Family Involvement in CBGT of OCD: a Randomized Controlled Trial

With a lifetime prevalence of 1-3% Obsessive-Compulsive Disorder (OCD) is a chronic and disabling psychiatric disorder with considerable burden for the individual and society....

Sponsor: University Hospital, GhentEnrolling: 801 location
RECRUITINGNCT05961306

Diagnostic Accuracy of the Stepped Screening Protocol and Its Screening Tools in the Perinatal Period.

It is known that 1 in 5 women experience psychological difficulties during their pregnancy or in the first year after giving birth. Unfortunately, in 75% of cases, these problems...

Sponsor: University Hospital, GhentEnrolling: 18002 locations
RECRUITINGNCT07198594

Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder

The goal of this clinical trial is to learn if individualized accelerated repetitive transcranial magnetic stimulation (rTMS) targeting the inferior frontal cortex combined with...

Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji UniversityEnrolling: 201 location
RECRUITINGNCT03918577

Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders

This study investigates whether caloric vestibular stimulation can modulate a measure of insight in obsessive-compulsive spectrum disorders.

Sponsor: Stanford UniversityEnrolling: 161 location
RECRUITINGPhase 2NCT03826693

Efficacy of Nitrous Oxide in OCD: Pilot Study

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

Sponsor: Stanford UniversityEnrolling: 451 location

Showing 50 of 59 trials.Search all Obsessive-Compulsive Disorder trials

Frequently Asked Questions

There are currently 59 clinical trials for Obsessive-Compulsive Disorder, with 59 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Obsessive-Compulsive Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Obsessive-Compulsive Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

this entity is one of the data points covered by this site’s U.S. clinical trials and research registries dataset. The detail above comes directly from the NIH ClinicalTrials.gov registry; the context that follows situates the headline numbers against the broader distribution across active and historical clinical trials.

The methodology behind every numeric value on this page is publicly documented on the the NIH ClinicalTrials.gov registry portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within active and historical clinical trials. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.